A COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF FIDAXOMICIN FOR TREATING CLOSTRIDIUM DIFFICILE PATIENTS IN GERMANY

被引：1
|
作者：
Watt, M. [1 ]
McCrea, C. [2 ]
Johal, S. [3 ]
Posnett, J. [2 ]
Nazir, J. [1 ]
机构：
[1] Astellas, Chertsey, Surrey, England
[2] Heron Commercializat, London, England
[3] Parexel Int, London, England
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.1357
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN33
引用
收藏
页码：A233 / A233
页数：1
相关论文
共 50 条
  • [21] Extended-pulsed fidaxomicin versus vancomycin in patients 60years and older with Clostridium difficile infection: cost-effectiveness analysis in Spain
    Rubio-Terres, Carlos
    Maria Aguado, Jose
    Almirante, Benito
    Cobo, Javier
    Grau, Santiago
    Salavert, Miguel
    Antona Sanchez, Elena Gonzalez
    Lopez Gutierrez, Cristina
    Rubio-Rodriguez, Dario
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2019, 38 (06) : 1105 - 1111
  • [22] The economic effectiveness of fidaxomicin over vancomycin in treating clostridium difficile infection in cancer patients: A systematic review
    Abughanimeh, Omar Khaled Mahmoud
    Al Momani, Laith
    Morgan, Tyler
    Abu Ghanimeh, Mouhanna
    Pluard, Timothy J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [23] DECISION ANALYSIS MODEL EVALUATING THE COST-EFFECTIVENESS OF FIDAXOMICIN AND VANCOMYCIN IN THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION (CDI) FROM A HOSPITAL PERSPECTIVE
    Alowayesh, M. S.
    Holdford, D.
    Harpe, S. E.
    VALUE IN HEALTH, 2012, 15 (04) : A243 - A243
  • [24] COST-EFFECTIVENESS OF BEZLOTOXUMAB AND FIDAXOMICIN FOR RECURRENT C. DIFFICILE INFECTION
    Chen, J.
    Gong, C.
    Hitchcock, M. M.
    Holubar, M.
    Deresinski, S.
    Hay, J. W.
    VALUE IN HEALTH, 2020, 23 : S170 - S170
  • [25] COST-EFFECTIVENESS ANALYSIS OF TREATMENT STRATEGIES FOR INITIAL CLOSTRIDIUM DIFFICILE INFECTION
    Biltaji, E.
    Varier, R.
    Smith, K.
    Roberts, M.
    Lafleur, J.
    Nelson, R. E.
    VALUE IN HEALTH, 2014, 17 (03) : A38 - A38
  • [26] COST-EFFECTIVENESS ANALYSIS OF MULTIPLE STRATEGIES FOR RECURRENT CLOSTRIDIUM DIFFICILE INFECTION
    Luo, Yuying
    Lucas, Aimee L.
    Grinspan, Ari
    GASTROENTEROLOGY, 2018, 154 (06) : S191 - S192
  • [27] A Cost-Effectiveness and Budget Impact Analysis of AbobotulinumtoxinA in Greece
    Nomikos, Nikolaos
    Eleftheriou, Christos
    Athanasakis, Kostas
    TOXINS, 2023, 15 (09)
  • [28] Comparative Effectiveness of Fidaxomicin for Treatment of Clostridium Difficile Infection
    Gidengil, Courtney A.
    Caloyeras, John P.
    Hanson, Mark
    Hillestad, Richard
    Mattke, Soeren
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2014, 6 (04) : 160 - 170
  • [29] COST-EFFECTIVENESS ANALYSIS OF FECAL MICROBIOTA TRANSPLANTATION IN PATIENTS WITH CLOSTRIDIUM DIFFICILE INFECTION IN HONG KONG
    Jiang, M.
    Leung, N.
    You, J.
    VALUE IN HEALTH, 2018, 21 : S65 - S65
  • [30] EMICIZUMAB PROPHYLAXIS IN HAEMOPHILIA A PATIENTS WITH INHIBITORS: A COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS
    Cortesi, P. A.
    Castaman, G.
    Trifiro, G.
    Ferrario, M.
    Improta, G.
    Mazzaglia, G.
    Molinari, A. C.
    Mantovani, L. G.
    VALUE IN HEALTH, 2019, 22 : S845 - S845
12345